drugset / Trial / NCT05106517
Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Bone mineral density and function at 1 year after screw fixation with denosumab vs zoledronic acid for osteoporotic vertebral compression fractures: a parallel double-blind randomized controlled clinical trial
Timeline
- Start
- 2021-09-08
- Primary completion
- 2023-03-05
- Completion
- 2023-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denosumab | Monoclonal antibody | 60 mg | Subcutaneous |
| Subject | Zoledronic acid | Other / unclassified | — | Intravenous |
Indications
No indication recorded.